2020 Cancer Communications Committee All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution Name Employment Leadership Stock and Other Honoraria Consulting or Advisory Speakers' Bureau Research Funding Patents, Royalties, Other Expert Testimony Travel, Other Relationship (OPTIONAL) (OPTIONAL) Open Ownership Interests Role Intellectual Property Accommodations, Uncompensated Payments Link Expenses Relationships
Neeraj Agarwal Astellas Pharma Active Biotech (Inst) AstraZeneca Amgen (Inst) AstraZeneca AstraZeneca (Inst) Bayer Bavarian Nordic (Inst) Bristol-Myers Squibb Bayer (Inst) Eisai BN ImmunoTherapeutics Exelixis (Inst) Foundation Medicine Bristol-Myers Squibb (Inst) Foundation One Inc Calithera Biosciences (Inst) Janssen Oncology Celldex (Inst) Lilly Eisai (Inst) Lilly Exelixis (Inst) lily Genentech (Inst) Medivation/Astellas GlaxoSmithKline (Inst) Merck Immunomedics (Inst) Nektar Janssen (Inst) Novartis Merck (Inst) Pfizer Newlink Genetics (Inst) Pfizer Novartis (Inst) Pharmacyclics Pfizer (Inst) Prometheus (Inst) Rexahn Pharmaceuticals (Inst) Sanofi (Inst) Takeda (Inst) TRACON Pharma (Inst)
Muhammad S. Beg Array BioPharma Bristol-Myers Squibb Agios (Inst) Boston Biomedical Ipsen ArQule (Inst) Ipsen AstraZeneca/MedImmune (Inst) Bristol-Myers Squibb (Inst) CASI Pharmaceuticals (Inst) Celgene (Inst) Five Prime Therapeutics (Inst) Genentech (Inst) Immunesensor (Inst) MedImmune (Inst) Merck Serono (Inst) Sillajen (Inst) Tolero Pharmaceuticals (Inst)
Suzanne Cole Research to Practice William Dale Robert Dreicer Astellas Pharma Bristol-Myers Squibb (Inst) AstraZeneca Genentech (Inst) Eisai Janssen Oncology (Inst) Genentech/Roche Seattle Genetics (Inst) Janssen Oncology Modra Pharmaceuticals Novartis Orion Pharma GmbH Pfizer Seattle Genetics/Astellas Vizuri
Maha H. Hussain Astellas Pharma AstraZeneca AstraZeneca (Inst) #TITLE: SYSTEMS AND Astellas Pharma Astellas Pharma Bayer Bayer (Inst) METHODS FOR TISSUE Bayer Genentech Genentech Genentech (Inst) IMAGING, 3676 Genentech MLI PeerView Pfizer PCCTC (Inst) Our File: Genentech/Roche PER Pfizer (Inst) Serial Number: Pfizer PER LLC Pfizer (Inst) UM-14437/US- Phillips Gilmore Oncology 1/PRO projects in Knowledge 60/923,385 Research to Practice UM-14437/US- RTP 2/ORD Sanofi/Genzyme 12/101,753 US 8,185,186 (US patent number) Systems and methods for tissue imaging (issued patent) EP 08745653.9 (EP application number) Systems and methods for tissue imaging (pending) CA 2683805 (Canadian application number) Systems and methods for tissue imaging (pending) US 13/362,500 (US application number) Systems and Methods for Tissue Imaging (continuation application of US 8,185,186)
#TITLE: METHOD OF TREATING CANCER Docket No: Serial Number: 224990/10- 016P2/311733 Randall J. Kimple Galera Therapeutics Igynta #Patent licensed through International Journal of the Univ of North Carolina. Radiation Oncology (I) Biology and Physics
#Patent licensed through the Wisconsin Alumni Research Fund (I)
Miriam Knoll Bristol Myers Squibb Catherine S. Magid Diefenbach Gilead Sciences Bayer Bristol-Myers Squibb (Inst) Bristol-Myers Squibb Genentech (Inst) Celgene Incyte (Inst) Genentech/Roche Janssen (Inst) Janssen LAM Therapeutics (Inst) Merck MEI Pharma (Inst) MorphoSys Merck (Inst) Seattle Genetics Millennium (Inst) Roche/Genentech (Inst) Seattle Genetics (Inst) Trillium Therapeutics (Inst)
Merry Jennifer Markham Aduro Biotech (Inst) Lilly (Inst) Novartis (Inst) Tesaro (Inst) VBL Therapeutics (Inst) Jane L. Meisel Total Health Conferencing Pfizer Lilly Pfizer Puma Biotechnology Pfizer Puma Biotechnology Seattle Genetics Total Health Conferencing
Sumanta K. Pal Astellas Pharma Medivation Aveo Bristol-Myers Squibb Eisai Exelixis Genentech Ipsen Myriad Pharmaceuticals Novartis Pfizer
Nathan A. Pennell AstraZeneca Altor BioScience (Inst) Bristol-Myers Squibb AstraZeneca (Inst) Cota Healthcare Bristol-Myers Squibb (Inst) Inivata Celgene (Inst) Lilly Genentech (Inst) Merck Loxo (Inst) Regeneron Merck (Inst) Pfizer (Inst) Spectrum Pharmaceuticals (Inst)
Carlos Rodriguez-Galindo Lidia Schapira Rubedo, Bluenote Therapeutics Richard Schilsky AstraZeneca, Bayer, Bristol- https://openpayments Myers Squibb, data.cms.gov/physician Genentech/Roche, Lilly, Merck, Pfizer, Boehringer /1138818/summary Poehringer Varian Sonali M. Smith Abbvie/Genentech Acerta AstraZeneca Pharma/AstraZeneca Bayer Celgene Bristol-Myers Squibb Pharmacyclics/Janssen Celgene Gilead Sciences Kite Pharma Pharmacyclics Portola Pharmaceuticals Seattle Genetics TG Therapeutics Mario Sznol Actym Therapeutics Abbvie AcademicCME Adaptive Biotechnologies Adaptimmune CEC Oncology Amphivena Allakos Clinical Care Options Intensity Therapeutics Almac Diagnostics DAVAOncology Nextcure Anaeropharma Haymarket Media Torque Anaeropharma Imedex Array BioPharma Physician Education AstraZeneca/MedImmune Resource Biodesix Prime Oncology Bristol-Myers Squibb Research to Practice Celldex TRM Oncology Chugai/Roche Vindico Genentech/Roche Genmab Genocea Biosciences GI Innovation Gritstone Oncology Hinge immunocore Incyte Innate Pharma Inovio Pharmaceuticals Kyowa Hakko Kirin Lilly Merck Sharp & Dohme Modulate Molecular Partners Nektar Newlink Genetics Novartis Omniox Pieris Pharmaceuticals Pierre Fabre Seattle Genetics Symphogen Robert G. Uzzo Genentech/RocheTh Janssen Oncology Novartis Pfizer Urogen pharma Shannon N. Westin AstraZeneca ArQule Bioascend AstraZeneca Casdin Capital Bayer Circulogene Theranostics Celgene (I) Clovis Oncology Curio Science LLC Curio Sciences Genentech Gerson Lehrman Group GlaxoSmithKline Medscape Merck Clovis Oncology Novartis Cotinga Pharmaceuticals OncLive GOG Foundation (Inst) Pfizer Karyopharm Therapeutics Roche (I) Targeted Oncology Tesaro Vaniam Group Watermark Research Partners
Kite Pharma (I)
Novartis Roche/Genentech Tesaro